Lauren P. Silvernail
2018
In 2018, Lauren P. Silvernail earned a total compensation of $1.3M as Former Chief Financial Officer and Chief Business Officer at Revance Therapeutics, a 17% decrease compared to previous year.
Compensation breakdown
| Option Awards | $824,577 |
|---|---|
| Salary | $245,916 |
| Stock Awards | $236,844 |
| Other | $27,400 |
| Total | $1,334,737 |
Silvernail received $824.6K in option awards, accounting for 62% of the total pay in 2018.
Silvernail also received $245.9K in salary, $236.8K in stock awards and $27.4K in other compensation.
Rankings
In 2018, Lauren P. Silvernail's compensation ranked 7,749th out of 14,244 executives tracked by ExecPay. In other words, Silvernail earned more than 45.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,749 out of 14,244 | 46th |
Division Manufacturing | 3,024 out of 5,765 | 48th |
Major group Chemicals And Allied Products | 1,132 out of 2,128 | 47th |
Industry group Drugs | 955 out of 1,817 | 47th |
Industry Pharmaceutical Preparations | 744 out of 1,391 | 47th |
Source: SEC filing on March 25, 2019.
Silvernail's colleagues
We found six more compensation records of executives who worked with Lauren P. Silvernail at Revance Therapeutics in 2018.
2018
L Browne
Revance Therapeutics
Chief Executive Officer
2018
Caryn McDowell
Revance Therapeutics
General Counsel
2018
Abhay Joshi
Revance Therapeutics
Chief Operating Officer
2018
Tobin Schilke
Revance Therapeutics
Chief Financial Officer
2018
Todd Zavodnick
Revance Therapeutics
Former Chief Commercial Officer and President, Aesthetics & Therapeutics
2018
Cyril Allouche
Revance Therapeutics